3/27
02:15 pm
dvax
Global Human Vaccines Market (2023-2028) [Yahoo! Finance]
Low
Report
Global Human Vaccines Market (2023-2028) [Yahoo! Finance]
3/25
08:20 am
dvax
Those who invested in Dynavax Technologies (NASDAQ:DVAX) five years ago are up 68% [Yahoo! Finance]
Low
Report
Those who invested in Dynavax Technologies (NASDAQ:DVAX) five years ago are up 68% [Yahoo! Finance]
3/24
07:57 am
dvax
Dynavax Technologies: Still A Believer [Seeking Alpha]
Low
Report
Dynavax Technologies: Still A Believer [Seeking Alpha]
3/23
08:41 am
dvax
Dynavax: Holding Firm Despite Its Missing Cash Cow [Seeking Alpha]
Low
Report
Dynavax: Holding Firm Despite Its Missing Cash Cow [Seeking Alpha]
3/14
05:19 am
dvax
Dynavax CFO Kelly MacDonald: Making An Impact In The Biotech Industry [Forbes]
Low
Report
Dynavax CFO Kelly MacDonald: Making An Impact In The Biotech Industry [Forbes]
3/12
09:28 am
dvax
Vaccine Adjuvants Market to Reach $1.5Billion Globally, By 2032 at 4% CAGR: Allied Market Research [Yahoo! Finance]
Low
Report
Vaccine Adjuvants Market to Reach $1.5Billion Globally, By 2032 at 4% CAGR: Allied Market Research [Yahoo! Finance]
3/6
11:04 pm
dvax
Dynavax Technologies Co. (NASDAQ: DVAX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Dynavax Technologies Co. (NASDAQ: DVAX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
3/6
03:37 pm
dvax
ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Vaccine Among People Living With HIV Who Have Not Previously Responded to Vaccination [Yahoo! Finance]
Low
Report
ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Vaccine Among People Living With HIV Who Have Not Previously Responded to Vaccination [Yahoo! Finance]
3/5
12:04 am
dvax
Chief Accounting Officer Justin Burgess Sells Shares of Dynavax Technologies Corp (DVAX) [Yahoo! Finance]
Low
Report
Chief Accounting Officer Justin Burgess Sells Shares of Dynavax Technologies Corp (DVAX) [Yahoo! Finance]
2/27
06:54 pm
dvax
Dynavax to Present at TD Cowen's 44th Annual Health Care Conference
Low
Report
Dynavax to Present at TD Cowen's 44th Annual Health Care Conference
2/23
11:41 am
dvax
Dynavax Technologies Co. (NASDAQ: DVAX) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Dynavax Technologies Co. (NASDAQ: DVAX) had its "outperform" rating re-affirmed by analysts at William Blair.
2/23
10:50 am
dvax
Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/22
08:19 pm
dvax
Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/22
04:57 pm
dvax
Dynavax Technologies Corp (DVAX) Reports Robust Revenue Growth and Market Leadership in 2023 [Yahoo! Finance]
Low
Report
Dynavax Technologies Corp (DVAX) Reports Robust Revenue Growth and Market Leadership in 2023 [Yahoo! Finance]
2/22
04:07 pm
dvax
Dynavax GAAP EPS of $0.00 beats by $0.01, revenue of $55.6M beats by $2.87M [Seeking Alpha]
Low
Report
Dynavax GAAP EPS of $0.00 beats by $0.01, revenue of $55.6M beats by $2.87M [Seeking Alpha]
2/22
04:04 pm
dvax
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance [Yahoo! Finance]
Low
Report
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance [Yahoo! Finance]
2/22
04:01 pm
dvax
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance
Low
Report
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance
2/21
11:43 am
dvax
Vaccine Adjuvants Market Global Industry Analysis 2018-2028: Expanding Human Vaccine Adjuvants Segment and Rising Infectious Disease Threats Propel Market Advancements [Yahoo! Finance]
Low
Report
Vaccine Adjuvants Market Global Industry Analysis 2018-2028: Expanding Human Vaccine Adjuvants Segment and Rising Infectious Disease Threats Propel Market Advancements [Yahoo! Finance]
2/8
04:15 pm
dvax
Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024
Low
Report
Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024
2/1
07:27 am
dvax
Dynavax Technologies Co. (NASDAQ: DVAX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $20.00 price target on the stock.
Low
Report
Dynavax Technologies Co. (NASDAQ: DVAX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $20.00 price target on the stock.
1/25
11:18 am
dvax
Vaccine Adjuvants Market Set to Soar Past USD 2.90 Billion by 2030 [Yahoo! Finance]
Low
Report
Vaccine Adjuvants Market Set to Soar Past USD 2.90 Billion by 2030 [Yahoo! Finance]
1/8
09:12 am
dvax
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights [Yahoo! Finance]
Medium
Report
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights [Yahoo! Finance]
1/8
09:00 am
dvax
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
Medium
Report
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
1/5
10:27 am
dvax
Dynavax Technologies (DVAX) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]
Low
Report
Dynavax Technologies (DVAX) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]
1/3
06:33 pm
dvax
Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Medium
Report
Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference